Laura M. Jacobsen

1. Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect Profile
   2026/06/12 by Laura M. Jacobsen, Dave Cuthbertson, JAMIE FELTON +11 · 1 voice
   Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer Immunotherapy and Biomarkers #Diabetes Management and Research #Diabetes and associated disorders
2. C-Peptide Provides Critical Contextual Insight Into Elevated Glucose Values During Progression to Type 1 Diabetes
   2026/04/30 by Emily K. Sims, Jay S. Skyler, Laura M. Jacobsen +5 · 1 voice
   Biochemistry, Genetics and Molecular Biology · Medicine · #Diabetes Management and Research #Diabetes and associated disorders #Pancreatic function and diabetes
3. Accounting for Age-Related Increases in HbA1c More Accurately Quantifies Risk of Type 1 Diabetes Progression in Islet Autoantibody–Positive Adults
   2026/05/06 by Erin L. Templeman, Nick Thomas, Susan Martin +13 · 1 voice
   Biochemistry, Genetics and Molecular Biology · Medicine · #Diabetes Management and Research #Diabetes and associated disorders #Pancreatic function and diabetes
4. Low-Dose Antithymocyte Globulin in Type 1 Diabetes: Real-World Exploratory Observation of C-Peptide by Modified Quantitative Response (mQR)
   2026/05/05 by David Weber, Joshua Modeste, Sarah Peeling +5 · 1 voice
   Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Diabetes Management and Research #Diabetes and associated disorders #T-cell and B-cell Immunology